Hillman Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$7.18M |
| 2 |
Adobe
ADBE
|
+$6.78M |
| 3 |
Estee Lauder
EL
|
+$2.92M |
| 4 |
Warner Bros
WBD
|
+$2.06M |
| 5 |
CVS Health
CVS
|
+$644K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$10.9M |
| 2 |
JWN
Nordstrom
JWN
|
+$2.14M |
| 3 |
Amazon
AMZN
|
+$1.77M |
| 4 |
GSK
GSK
|
+$1.61M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.45% |
| 2 | Consumer Staples | 15.24% |
| 3 | Communication Services | 14.61% |
| 4 | Financials | 12.23% |
| 5 | Technology | 10.96% |
Similar funds
Hillman Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, Hillman Capital Management held 54 positions worth $283M, down 9% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Hillman Capital Management withdrew a net $10.4M in Q2 2024, closing 1 position and reducing 38 holdings. Its most notable exit was TSMC, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Communication Services.
Against the trend, Hillman Capital Management opened a new position in Bristol-Myers Squibb worth $6.67M.
- Hillman Capital Management's largest Q2 2024 buy was Bristol-Myers Squibb: 160,529 shares worth $6.67M.
- Hillman Capital Management added most to Estee Lauder in Q2 2024, an estimated $2.92M increase.
- Hillman Capital Management's biggest Q2 2024 reduction was Nordstrom, cutting an estimated $2.14M.
- Hillman Capital Management fully exited TSMC in Q2 2024, selling an estimated $10.9M.
- Hillman Capital Management's ten largest holdings make up 32% of its $283M portfolio in Q2 2024.
- Hillman Capital Management opened 2 new positions and closed 1 in Q2 2024.
- Hillman Capital Management's portfolio value fell 9% quarter-over-quarter to $283M.
Based on Hillman Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.